Login / Signup

Biases affecting injected doses of an experimental drug during clinical trials.

Nancy PerrottetFrançoise Brunner-FerberEric GrouzmannFrançois SpertiniJérôme BiollazThierry BuclinNicolas Widmer
Published in: Trials (2016)
Clinicaltrials.gov NCT02515695 (Trial A) and NCT02517788 (Trial B). Registered on 24 July and 5 August 2015, respectively.
Keyphrases
  • clinical trial
  • phase iii
  • phase ii
  • study protocol
  • open label
  • randomized controlled trial
  • double blind
  • emergency department
  • adverse drug
  • placebo controlled